1.Role and mechanism of resveratrol in a rat model of complex regional pain syndrome type Ⅰ
Chunyan GUO ; Xiaole SHI ; Qianyu LI ; Yuzhu LIU ; Rui WU
The Journal of Practical Medicine 2017;33(11):1761-1764
Objective To investigate the role and mechanism of resveratrol in a rat model of complex region-al pain syndrome type Ⅰ(CRPS1). Methods 50 male SD rats were divided into control group(group A),sham operation group(group B),model group 1(group C),model group 2(group D),and model group 3(group E). Groups A,B and C received 5%DMSO;group D received ISO-1 of 1 mg/(kg·d);and group E received resveratrol of 20 mg/(kg · d)for 14 days. Pain behaviors were assessed on days 0,7,and 14. Serum levels of MIF and TNF-αwere detected by ELISA. MIF ,total ERK1/2 and p-ERK1/2 in sciatic nerve were detected by Western blot. Re-sults On days 7 and 14 after treatment,resveratrol injection,similar to ISO-1,significantly improved the pain threshold;serum levels of MIF and TNF-α were significantly decreased;expressions of MIF ,total ERK1/2 and p-ERK1/2 in sciatic nerve were also decreased significantly in group E,which were significantly lower than group C (P < 0.05). Conclusions Resveratrol can significantly improve pain threshold ,decrease expressions of MIF and p-ERK1/2 in a rat model of CRPS1,which might be involved in the inhibition of ERK signaling pathway.
2.Comparative study of clinical characteristics between adult patients with adenovirus type 7 and type 55 infections in China during 2012-2018
Xiaole MEI ; Weiwei CHEN ; Wengang LI ; Wen XU ; Zhe XU ; Bo TU ; Enqiang QIN ; Lei SHI ; Peng ZHAO ; Min ZHAO
Chinese Journal of Infectious Diseases 2019;37(4):193-198
Objective To compare and explore the differences of clinical characteristics between human adenovirus type 7 (HAdV7) and type 55 (HAdV55) infections in adults,and to provide evidences for clinical management.Methods The data of clinical manifestations,laboratory examinations,chest computed tomography and prognosis of 214 cases with HAdV7 and 235 cases with HAdV55 infections from 2012 to 2018 were retrospectively collected and analyzed.The chi-square test was used for the categorical variables,and the rank sum test was used for the continuous variables of non-normal distribution.Results Compared with patients in HAdV55,those in HAdV7 group displayed more diarrhea (12.1% [26/214] vs 2.6% [6/235],x2 =15.583),more laryngeal lymphatic follicles (33.2% [71/214] vs 17.9% [42/235],x2 =23.566),more tonsil enlargement (56.5% [121/214] vs 20.0% [47/235],x2 =63.870) with secretions (33.2% [71/214] vs 11.5% [27/235],x2 =30.878),more leukocytosis (24.8% [53/214] vs 14.0% [33/235],x2 =8.318),more monocytosis (78.0% [167/214] vs 52.8% [124/235],x2 =31.364),more thrombocytosis (7.1% [15/212] vs 3.8% [9/235],x2 =5.835),more elevated level of C-reactive protein (80.8% [97/120] vs 64.3% [137/213],x2 =10.020),more abnormalities of liver function (alamne aminotransferase [ALT]:13.5% [28/207] vs 5.6% [13/232],x2 =8.111) and myocardial enzymes (creatine kinase [CK]:37.6% [77/205] vs 26.4% [61/231],x2 =6.246),creatine kinase isoenzymes ([CK-MB]:35.6% [73/205] vs 11.1% [24/216],x2 =35.600),and all the differences were statistically significant (all P < 0.05,0.01).Compared with patients in HAdV7 group,those in HAdV55 group displayed longer duration of diseases (7 [5]days vs 6[5] days,Z=-2.632),more sore throat (72.8% [171/235] vs 62.1% [133/214],x2 =0.016),more headache (62.1% [146/235] vs 16.4% [35/214],x2 =97.527),more pharyngeal congestion (93.6% [220/235]vs 74.8% [160/214],x2 =30.602),more leukopenia (14.0% [33/235] vs 24.8% [53/214],x2 =8.318),and more elevated level of lactate dehydrogenase (12.6% [29/230] vs 6.3% [13/205],x2 =4.881),more pneumonia (71.5% [168/235] vs31.8% [68/214],x2 =70.846) (all P<0.05,0.01).Conclusions The clinical characteristics of HAdV7 and HAdV55 infections in adults are different.The type 55 infection is more likely to develop to pneumonia,while the type 7 infection has wider tissue tropism.